Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1,150,714
-
Shares change
-
+34,621
-
Total reported value, excl. options
-
$3,170,000
-
Value change
-
+$191,545
-
Put/Call ratio
-
17.2%
-
Number of buys
-
16
-
Number of sells
-
-4
-
Price
-
$2.75
Significant Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q1 2021
30 filings reported holding RKDA - Arcadia Biosciences, Inc. - Common Stock as of Q1 2021.
Arcadia Biosciences, Inc. - Common Stock (RKDA) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,150,714 shares
of 1,390,020 outstanding shares and own 82.8% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (380,906 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (135,505 shares), GEODE CAPITAL MANAGEMENT, LLC (89,995 shares), MILLENNIUM MANAGEMENT LLC (88,960 shares), Moloney Securities Asset Management, LLC (71,750 shares), SABBY MANAGEMENT, LLC (67,136 shares), BOOTHBAY FUND MANAGEMENT, LLC (61,544 shares), LPL Financial LLC (42,500 shares), WELLS FARGO & COMPANY/MN (37,000 shares), and Bayesian Capital Management, LP (36,100 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.